Influence of Yoga in Patients With Neurocardiogenic Syncope
SYNC - YOGA
Neurocardiogenic Syncope and the Role That Yoga Plays in People With Autonomic Dysfunction
1 other identifier
interventional
8
1 country
1
Brief Summary
Syncope is a common problem that many clinicians may encounter in various outpatient settings. Neurocardiogenic syncope (NCS) is a benign condition characterized by a self limited episode of systemic hypotension. Patients are usually managed with education on syncope, anxiety management, and coping skills. It has been established that practice of Yoga could relieve stress and anxiety. In a different study, they also found that Yoga positively influences cardiovascular function by decreasing the heart rate and blood pressure. The main objective of Yoga is to achieve control over the autonomic nervous system and able to control functions like heart rate, blood pressure and respiratory rate. Based on the findings that Yoga relieves stress and reduces heart rate, the investigators propose to study if Yoga can decrease the frequency of NCS and also reduce the symptoms associated with these episodes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for early_phase_1
Started Jun 2012
Typical duration for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 5, 2012
CompletedFirst Posted
Study publicly available on registry
September 28, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedJune 30, 2015
June 1, 2015
2.7 years
July 5, 2012
June 27, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in frequency of recurrent syncopal spells in patients with Neurocardiogenic syncope (NCS)
Differences in the incidence of syncopal spells pre and post Yoga.
Baseline to 3 Months
Change in frequency of recurrent syncopal spells in patients with Neurocardiogenic syncope (NCS)
Differences in the incidence of syncopal spells pre and post Yoga.
Baseline to 1 Year
Change in frequency of recurrent syncopal spells in patients with Neurocardiogenic syncope (NCS)
Differences in the incidence of syncopal symptoms pre and post Yoga.
Baseline to 1 Year
Secondary Outcomes (1)
Change in Heart Health
3 Months, 1 Year
Study Arms (1)
Yoga
EXPERIMENTALParticipants will be asked to practice Yoga 3 times per week at a minimum, and daily at a maximum. Participants will receive training in different Yoga techniques including breathing exercises, postures and meditation. Participants will be asked to practice 1 hour Yoga sessions comprised of breathing exercises, postures and meditation.
Interventions
Includes breathing exercises, postures, and meditation. Participant practices yoga at their home a minimum of 3 times per week for 1 hour per time. Participation can last for up to 1 year.
Eligibility Criteria
You may qualify if:
- Diagnosis of recurrent Neurocardiogenic syncope
- At least one episode of syncope or pre-syncopal event in the last 3 months prior to enrollment
You may not qualify if:
- Previously established diagnosis of any psychiatric illness.
- Previous history of Coronary Artery Disease, myocardial infarction, congestive heart failure, carotid sinus hypersensitivity
- Established diagnosis of tachy and/or brady arrhythmias, except cardioinhibiotry neurocardiogenic syncope.
- History of pacemaker, ICD or CRT-D implantation.
- Other conditions where Yoga should be avoided are:
- Pregnant women
- Subjects with untreated or uncontrolled high blood pressure
- Subjects with past history of Pnuemothorax.
- Subjects with severe cervical spondylitis and cervical, thoracic or lumbar disc prolapse.
- Subjects with carotid stenosis
- Subjects with history of psychosis (evidence of acute episodes with deep and prolonged meditation) or substance abuse.
- Subjects with the history of epilepsy ( evidence of acute episodes with deep and prolonged meditation)
- Subjects with glaucoma
- Subjects with history of Total Hip Replacement.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dhanunjaya Lakkireddy, MD, FACC
University of Kansas Medical Center
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
July 5, 2012
First Posted
September 28, 2012
Study Start
June 1, 2012
Primary Completion
March 1, 2015
Study Completion
March 1, 2015
Last Updated
June 30, 2015
Record last verified: 2015-06